RayzeBio Funding: $418M Raised, Series D (2022)

RayzeBio funding overview

RayzeBio is based in San Diego, CA. RayzeBio has raised $418M in total disclosed funding. That places its disclosed total in the $250M–$1B range. Its most recent disclosed round is a Series D announced in October 2022. The round record for RayzeBio runs through 2022; nothing later has been disclosed. Investors on record include venBio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors, Samsara BioCapital. 5 distinct backers are named across the disclosed rounds.

RayzeBio at a glance

Total raised: $418M
Latest round: Series D
Latest round date: October 2022
Headquarters: San Diego, CA
Notable investors: venBio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors, Samsara BioCapital

Frequently asked about RayzeBio funding

How much has RayzeBio raised?: RayzeBio has raised $418M in total disclosed funding across the rounds on record.
Who has invested in RayzeBio?: venBio Partners, Venrock Healthcare Capital Partners, Versant Ventures, Viking Global Investors, Samsara BioCapital are named among the investors backing RayzeBio.
What was the latest RayzeBio funding round?: The most recent disclosed round is a Series D, announced in October 2022.
Where is RayzeBio based?: RayzeBio is based in San Diego, CA.
When did RayzeBio last raise?: The last disclosed RayzeBio round closed in October 2022 at Series D.

Totals shown for RayzeBio aggregate every disclosed round on file. To see how that compares, browse the companies in San Diego and the investors behind them below.

RayzeBio Funding: $418M Raised, Series D (2022)

RayzeBio funding overview

RayzeBio at a glance

Frequently asked about RayzeBio funding

Companies related to RayzeBio (36)

Browse related funding lists (9)